Greetings and welcome to the X4 Pharmaceuticals fourth quarter and full year 2024 financial and operating results conference call. (Operator Instructions) and it is now my pleasure to turn to your ...

X4 Pharmaceuticals highlights 2024 as transformative with XOLREMDI's U.S. launch, international expansion, & Phase 3 trial progress.

Phase 3 4WARD trial in chronic neutropenia now activated at ~90% of targeted trial sites; full enrollment expected in 3Q or 4Q 2025; top-line ...

The following is a summary of “Favorable correlation between neutrophil percentages obtained using automated hematology ...

Over the past decades, bronchiectasis has been neglected, despite the global burden.1,2 To date, better diagnosis due to easy ...

The Management of ELWA Hospital in Paynesville has expressed deep empathy and extended prayers to Madam Jamesetta J. Kugmeh and her family regarding her deteriorating health condition after undergoing ...

The Absolute Neutrophil Count (ANC) is calculated as part of a complete blood count (CBC) test, which estimates the baby's ability to fight infection. According to her, when she got to the hospital, ...

During a Case-Based Roundtable® event, Ryan W. Jacobs, MD, discussed a patient who received 2 prior lines of therapy for ...

JOHANNESBURG - The Democratic Alliance (DA) has accused the African National Congress (ANC) of being the modern-day oppressor of poor South Africans, describing its proposal to increase value ...